179 related articles for article (PubMed ID: 579134)
1. Comparison of the hypotensive and diuretic effects of 1,4-dimorpholino-7-phenylpyrido[3,4]pyridazine (DS-511) and hydrochlorothiazide in Doca, renal and spontaneously hypertensive rats.
Inada Y; Nishikawa K; Nagaoka A; Kikuchi S
Arzneimittelforschung; 1977; 27(9):1663-9. PubMed ID: 579134
[TBL] [Abstract][Full Text] [Related]
2. 1,4-Dimorpholino-7-phenylpyrido[3,4-d]pyridazine (SD-511) as a new type of diuretic agent.
Inada Y; Shibouta Y; Shimakawa H; Nishikawa K; Kikuchi S
Arzneimittelforschung; 1978; 28(7):1105-11. PubMed ID: 582697
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of 1,4-dimorpholino-7-phenylpyrido[3,4-d]-pyridazine (DS-511) and its 4'-hydroxy derivative on antidiuretic action of vasopressin in rats.
Shibouta Y; Nishikawa K; Kikuchi S
Arzneimittelforschung; 1978; 28(8):1398-403. PubMed ID: 582406
[TBL] [Abstract][Full Text] [Related]
4. Effect of the diuretic, 1,4-dimorpholino-7-phenylpyrido[3,4-d]-pyridazine (DS-511) and its derivatives on ADH-cyclic AMP system in rat renal medullary slices.
Shibouta Y; Nishikawa K; Kikuchi S
Arzneimittelforschung; 1978; 28(7):1112-5. PubMed ID: 226101
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,4-dimorpholino-7-(4-hydroxyphenyl)pyrido[3,4-d]) pyridazine [DS-511(4'-OH)] on the transepithelial transport of sodium and water and the permeability to urea in the toad urinary bladder.
Shida M; Nishikawa K; Kikuchi S
Arzneimittelforschung; 1979; 29(5):807-11. PubMed ID: 227423
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive activity of cadralazine in experimental hypertensive rats.
Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
[TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive and diuretic effects of indapamide in normotensive and hypertensive rats (author's transl)].
Morishita S; Nishimura K; Kato E; Shirahase H; Osumi S; Kitao K; Seki T
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):137-46. PubMed ID: 7084816
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
17. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
Nicholas TE
Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
[TBL] [Abstract][Full Text] [Related]
18. Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat.
Scalbert E; Abdon D; Devissaguet M; Juggi JS
Can J Cardiol; 1992 May; 8(4):381-6. PubMed ID: 1617521
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of besulpamide, a new diuretic, in rats and dogs.
Colombo M; Farré AJ; Fort M; Martínez L; Roser R; Sagarra R
Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):101-10. PubMed ID: 3295429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
